drugset
drugset / Trial / NCT03734042

PRP Intrauterine Infusion in Thawed Embryo Cycles

NCT03734042 ↗

Phase 4 Completed 102 enrolled Tanta University
RandomizedParallel-groupSingle-blindTreatment

Summary

All patients prepared to thawed embryo transfer were classified into 2 groups one group will receive platelet rich plasma (PRP) infusion intrauterine and the other group will not receive platelet rich plasma (PRP) infusion

Timeline

Start
2018-12-01
Primary completion
2021-10-31
Completion
2021-10-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Platelet Rich Plasma Other / unclassified — Other

Indications

No indication recorded.